<p>The invention encompasses novel biomarkers and methods for assessing insulin resistance in a subject. The novel biomarkers of the invention include various plasma constituent (e.g., insulin, glucose, lactate and/or triglyceride) concentrations. The methods of the invention include measuring various plasma constituent concentrations and calculating a predicted euglycemic hyperinsulinemic clamp glucose infusion rate (GIR) based on the plasma constituent concentrations.</p>
申请公布号
WO2006066263(A1)
申请公布日期
2006.06.22
申请号
WO2005US46324
申请日期
2005.12.16
申请人
ENTELOS, INC.;MICHELSON, SETH GARY;POLIDORI, DAVE;REED, MICHAEL;SILER, SCOTT;WENNERBERG, LEIF, GUSTAF
发明人
MICHELSON, SETH GARY;POLIDORI, DAVE;REED, MICHAEL;SILER, SCOTT;WENNERBERG, LEIF, GUSTAF